PETALING JAYA: The Health Ministry wants doctors to restrict the use of anti-diabetic drugs containing rosiglitazone and stop starting new patients on such drugs over safety concerns
Health Ministry director-general Tan Sri Dr Mohd Ismail Merican said in a statement on Sunday that the European Medicines Agency (EMA) on Thursday suspended the use of anti-diabetic drugs after a review by the Committee for Medical Products for Human Use (CHMP) of data about increased risk of adverse cardiovascular effects of rosiglitazone in anti-diabetic drugs like Avandia, Avandemet and Avaglim.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
